Abiopharma

🔍 Esch Kevin (Executive)

Company: Zoetis Inc. (ZTS)

Report Date: 2026-01-09

Detailed Transactions and Holdings:

• Acquired 34 shares of Phantom Stock Unit (Derivative)
  Date: 2026-01-09 | Code: A | equity_swap_involved: 0 | shares_owned_after: 277.04 | transaction_form_type: 4 | Footnotes: F1, F2, F1, F1

Footnotes:

• F1: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.
• F2: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.